Mesoblast Ltd. Files 6-K with Financial Updates
Ticker: MEOBF · Form: 6-K · Filed: Feb 27, 2025 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-update, sec-filing, balance-sheet
TL;DR
MESO filed its 6-K for 12/31/24, showing updated financials. Check the balance sheet.
AI Summary
Mesoblast Ltd. filed a 6-K report for the period ending December 31, 2024. The filing includes financial data for the six months ended December 31, 2024, and comparative periods. Key financial statement items such as issued capital, retained earnings, and various reserves are detailed.
Why It Matters
This filing provides investors with updated financial information for Mesoblast Ltd., crucial for assessing the company's financial health and performance.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) providing updated financial data, not indicating new risks or significant events.
Key Numbers
- 2024-12-31 — Period End Date (Latest financial reporting period)
- 2023-12-31 — Comparative Period End Date (Previous financial reporting period for comparison)
Key Players & Entities
- MESOBLAST LTD (company) — Filer of the report
- 2024-12-31 (date) — Period of report
- 2023-12-31 (date) — Comparative period
FAQ
What is the primary purpose of this 6-K filing?
The primary purpose of this 6-K filing is to provide updated financial information for Mesoblast Ltd. for the period ending December 31, 2024.
What specific financial periods are covered in this filing?
This filing covers the period ending December 31, 2024, and includes comparative data for the period ending December 31, 2023.
What type of company is Mesoblast Ltd. based on its SIC code?
Mesoblast Ltd. is classified under SIC code 2836, which pertains to Biological Products (No Diagnostic Substances).
Where is Mesoblast Ltd. headquartered?
Mesoblast Ltd. is headquartered in Melbourne, Victoria, Australia, with its business address at Level 38, 55 Collins Street, Melbourne, Victoria, 3000.
What are some of the key financial statement components mentioned in the filing?
Key financial statement components mentioned include Issued Capital, Retained Earnings, Reserve of Gains and Losses from Investments, Investment Revaluation Reserve, Reserve of Exchange Differences on Translation, and Reserve of Equity Component of Convertible Instruments.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 27, 2025 regarding MESOBLAST LTD (MEOBF).